Article: Sublingual immunotherapy safe in children under 5 years.(Pulmonary Medicine)

San Antonio -- Sublingual immunotherapy is safe and effective in children younger than 5 years--a group considered ideal for early allergy intervention, according to Italian researchers.

"Immunotherapy has been shown to prevent the onset of asthma in allergic patients. ... Therefore, children are optimal candidates," said Giovanni Passalacqua, M.D., professor of allergy and immunology at the University of Genoa, Italy.

He said concerns about the safety of subcutaneously administered allergy immunotherapy in children make the prospect of sublingual administration particularly appealing.

"Subcutaneous immunotherapy injections can provoke systemic ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!